Evidence map›Paper›PMID 29696999›Full record

ArticleJournal of health psychology2020

Sexual well-being and diurnal cortisol after prostate cancer treatment.

Michael A Hoyt, Allison E Gaffey, Ashley W Wang, Mark S Litwin, Catalina J Lawsin

Open access · greenAbstract read
In one paragraph

Article in Journal of health psychology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Michael A HoytHunter College, City University of New York, USA.ORCID 0000-0003-2274-1902
Allison E GaffeyRush University Medical Center, USA.
Ashley W WangHunter College, City University of New York, USA.
Mark S LitwinUniversity of California, Los Angeles, USA.
Catalina J LawsinRush University Medical Center, USA.
City University of New York · USRush University Medical Center · USUniversity of California, Los Angeles · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Emotion-Regulation, Inflammatory Processes, and Depression in Prostate Cancer SurSC1CA187494 · NCI · HUNTER COLLEGE · PI HOYT, MICHAEL A · 2014 to 2017
$1.6M
NCATS NIH HHS UL1 TR001863NCI NIH HHS L30 CA136998NCI NIH HHS P30 CA016042NCI NIH HHS SC1 CA187494
6 · The paper itself

Abstract

Sexual dysfunction and psychological distress are common after prostate cancer. Research has not examined the role of neuroendocrine markers of stress (e.g. cortisol). This study examines whether sexual functioning or sexual bother is associated with diurnal cortisol. Men treated for prostate cancer completed the University of California-Los Angeles Prostate Cancer Index and provided saliva samples four times daily for cortisol assessment. Higher sexual bother, but not sexual functioning, was associated with steeper cortisol slope. Better sexual functioning, and not sexual bother, was significantly associated with the cortisol awakening response. Assessment of stress and stress-reducing interventions might be warranted in sexual rehabilitation after prostate cancer.

Indexed as

HydrocortisoneProstatic NeoplasmsCircadian RhythmHumansHypothalamo-Hypophyseal SystemMalePituitary-Adrenal SystemSalivaHydrocortisonecortisolhypothalamic–pituitary–adrenal axisprostate cancersexual bothersexual functioning

Identifiers

PMID29696999
PMCPMC6309533
OpenAlexW2802247243

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.